The import of heterocyclic compounds with an unfused imidazole ring to India is expected to witness a steady increase from 2024 to 2028. In 2023, the actual import volume stood at 7.74 million kilograms. The forecast indicates a growth trend, reaching approximately 8.84 million kilograms by 2028. On a year-on-year basis, the expected variation is around 2.87% to 2.42% from 2024 to 2028. The compound annual growth rate (CAGR) over this five-year period is approximately 2.69%, suggesting a consistent positive upward trend.

Future trends to watch for in the Indian market include:

Potential shifts in pharmaceutical production due to policy changes impacting raw material imports.
Technological advancements in synthesis may influence supply chain efficiency.
Market demand driven by increased applications in pharmaceuticals and agriculture.